Hsbc Holdings PLC Has $315,000 Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Hsbc Holdings PLC increased its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 14.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 13,681 shares of the company’s stock after purchasing an additional 1,727 shares during the period. Hsbc Holdings PLC’s holdings in Option Care Health were worth $315,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. Tower Research Capital LLC TRC raised its position in shares of Option Care Health by 174.4% in the fourth quarter. Tower Research Capital LLC TRC now owns 11,142 shares of the company’s stock valued at $258,000 after purchasing an additional 7,082 shares during the period. MetLife Investment Management LLC raised its holdings in Option Care Health by 7.8% in the 4th quarter. MetLife Investment Management LLC now owns 197,219 shares of the company’s stock worth $4,575,000 after acquiring an additional 14,311 shares during the period. Dimensional Fund Advisors LP lifted its position in Option Care Health by 17.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company’s stock worth $92,518,000 after acquiring an additional 591,042 shares during the last quarter. Canada Pension Plan Investment Board boosted its holdings in Option Care Health by 59.7% during the fourth quarter. Canada Pension Plan Investment Board now owns 40,400 shares of the company’s stock valued at $937,000 after acquiring an additional 15,100 shares during the period. Finally, Marshall Wace LLP grew its position in shares of Option Care Health by 33.7% in the fourth quarter. Marshall Wace LLP now owns 1,097,714 shares of the company’s stock valued at $25,467,000 after purchasing an additional 276,765 shares during the last quarter. 98.05% of the stock is owned by institutional investors.

Insider Transactions at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.64% of the stock is currently owned by insiders.

Option Care Health Trading Up 0.4 %

Shares of Option Care Health stock opened at $31.84 on Friday. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The firm has a market capitalization of $5.21 billion, a PE ratio of 26.76, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The company’s fifty day moving average price is $33.24 and its two-hundred day moving average price is $28.90.

Option Care Health (NASDAQ:OPCH) last posted its earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.04. The business had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The firm’s revenue for the quarter was up 16.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.26 earnings per share. On average, analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

Wall Street Analyst Weigh In

OPCH has been the subject of several research analyst reports. Barrington Research reissued an “outperform” rating and set a $38.00 price objective on shares of Option Care Health in a research report on Wednesday, April 30th. UBS Group upgraded Option Care Health from a “neutral” rating to a “buy” rating and upped their price target for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and raised their price objective for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. JPMorgan Chase & Co. upped their target price on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th. Finally, Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price target for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $35.50.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.